scorecardresearch
Clear all
Search

COMPANIES

No Data Found

NEWS

No Data Found
Sign in Subscribe
SMS Pharmaceuticals Ltd
SMS Pharmaceuticals Ltd

SMS Pharmaceuticals Ltd (SMSPHARMA) Share Price

  • Sector: Pharmaceuticals (Small Cap)
  • Volume: 202457
Apr 07, 2025 15:53 IST Open
  • NSE
  • BSE
  • Share
    • Whatsapp
    • Twitter
    • Facebook
₹197.67
₹-12.10 (-5.77%)
Created with Highcharts 11.1.015:0016:3018:0019:3021:00185190195200205
₹188.00Low
Today’s Performance
₹205.00High
₹175.25Low
52 Week’s Performance
₹398.00High

STOCK ANALYSIS

STOCK PERFORMANCE

  • 1 Day-5.77%
  • 1 Week-1.41%
  • 1 Month9.94%
  • 3 Months-12.65%
  • 6 Months-42.39%
  • 1 Year6.27%
  • 3 Years27.04%
  • 5 Years46.68%

PEER COMPARISON

₹197.67SMS Pharmaceuticals Ltd
₹1,384.70Cipla Ltd

FINANCIAL ANALYSIS

Income Statement (₹ Cr.)
Created with Highcharts 11.1.0175.48175.48198.05198.05165.82165.82247.44247.4417.0817.0813.8613.8616.3716.3716.0516.05Total IncomeReported Profit After TaxDec 2024Sep 2024Jun 2024Mar 2024050100150200250300
Balance Sheet (₹ Cr.)
Cash Flow (₹ Cr.)
Income Statement (₹ Cr.)
Balance Sheet (₹ Cr.)
Cash Flow (₹ Cr.)

RATIO ANALYSIS

Return on Equity (%)
Created with Highcharts 11.1.09.769.7616.0716.0715.4115.410.830.839.879.8720202021202220232024024681012141618
Return on Assets (%)
Price-to-Earnings (P/E) (X)
Price to Book (x)
Return on Capital Employed (%)
Enterprise Value to EBITDA (X)
Net Profit Margin (%)
Gross Profit Margin (%)
EBITDA Margin (%)
Return on Equity (%)
Return on Assets (%)
Price-to-Earnings (P/E) (X)
Price to Book (x)
Return on Capital Employed (%)
Enterprise Value to EBITDA (X)
Net Profit Margin (%)
Gross Profit Margin (%)
EBITDA Margin (%)

SHAREHOLDING PATTERN

Summary (as on 31 Mar 2025)
  • Promoters (66.26%)
  • Domestic institutional investors (2.43%)
  • Foreign Institutional Investors (2.61%)
  • Public & Other(27.09%)
  • Government Holding(0.00%)
  • Corporate Holding(1.60%)
Created with Highcharts 11.1.066.2666.262.612.612.432.4327.0927.090.000.001.601.60
Created with Highcharts 11.1.066.2666.2664.6764.6764.6764.6764.6764.67Mar 2025Dec 2024Sep 2024Jun 2024010203040506070

DEALS

Dec 08, 2020 PURCHASE
HIMA BINDU POTLURI
  • Qty 1390480
  • Average Price ₹94.70
Dec 08, 2020 PURCHASE
RAMESH BABU POTLURI
  • Qty 1468100
  • Average Price ₹94.70
Dec 08, 2020 Sell
ANNAPURNA TALLURI
  • Qty 2858580
  • Average Price ₹94.70
Dec 07, 2020 PURCHASE
VAMSI KRISHNA POTLURI
  • Qty 4224680
  • Average Price ₹94.70
Dec 07, 2020 Sell
VEERAVENKATA SATYANARAYANA MURTHY TALLURI
  • Qty 4224680
  • Average Price ₹94.70
Nov 25, 2020 PURCHASE
VAMSI KRISHNA POTLURI
  • Qty 2795000
  • Average Price ₹82.40
*Single trade that involves transaction of a minimum quantity of 5 lakh shares or a minimum value of 10 crore.
Feb 12, 2024 Sell
GRAVITON RESEARCH CAPITAL LLP
  • Qty 492358
  • Average Price ₹154.49
Feb 12, 2024 Sell
DOVETAIL INDIA FUND CLASS 11 SHARES
  • Qty 500000
  • Average Price ₹152.45
Feb 12, 2024 PURCHASE
GRAVITON RESEARCH CAPITAL LLP
  • Qty 492358
  • Average Price ₹154.37
Dec 31, 2020 PURCHASE
POTLURI INFRA PROJECTS LLP
  • Qty 661180
  • Average Price ₹115.10
Dec 31, 2020 Sell
VEERAVENKATA SATYANARAYANA MURTHY TALLURI
  • Qty 661180
  • Average Price ₹115.10
Dec 08, 2020 PURCHASE
HIMA BINDU POTLURI
  • Qty 1390480
  • Average Price ₹94.70
*Involves transaction of at least 0.5% of the listed shares of a company.

FAQ’S

What was SMS Pharmaceuticals Ltd share price previously?
SMS Pharmaceuticals Ltd share price was down by -5.77% from the previous closing price of ₹209.77.
Who are peers of SMS Pharmaceuticals Ltd?
The peers of SMS Pharmaceuticals Ltd are Sun Pharmaceutical Industries Ltd, Divis Laboratories Ltd, Cipla Ltd, Torrent Pharmaceuticals Ltd, Mankind Pharma Ltd, Dr Reddys Laboratories Ltd, Lupin Ltd,
Who is/are the promoter/promoters of SMS Pharmaceuticals Ltd?
The promotor/promotors of SMS Pharmaceuticals Ltd are P Ramesh Babu, P Sarath Kumar, Thummala Neelaveni, Shravan Kudaravalli, Sarvepalli Srinivas, Vamsi Krishna Potluri, Thirumalesh Tumma, Trilok Potluri., Sunkara Venkata Satya Shiva Prasad, G Suresh Kumar, Shanti Sree Bolleni.
What has been 52-week high of SMS Pharmaceuticals Ltd stocks?
The highest price of SMS Pharmaceuticals Ltd stock is ₹398.00 in the last 52-week.
What is the share price of SMS Pharmaceuticals Ltd (SMSPHARMA) today on NSE?
As on Apr 07, 2025, SMS Pharmaceuticals Ltd (SMSPHARMA)’s share price on NSE is Rs 197.67
What is the market cap of SMS Pharmaceuticals Ltd (SMSPHARMA?)
The current market capitalisation of SMS Pharmaceuticals Ltd (SMSPHARMA) is 1,775.75 crores
What is SMS Pharmaceuticals Ltd Share symbol?
The symbol of SMS Pharmaceuticals Ltd is SMSPHARMA.
What is the PE ratio of SMS Pharmaceuticals Ltd (SMSPHARMA)?
The current PE ratio of SMS Pharmaceuticals Ltd (SMSPHARMA) is 26.87.
What is the PB ratio of SMS Pharmaceuticals Ltd (SMSPHARMA)?
The current PB ratio of SMS Pharmaceuticals Ltd (SMSPHARMA) is 3.15.
Today’s High & Low share prices of SMS Pharmaceuticals Ltd (SMSPHARMA) on NSE?
Today, the share price of SMS Pharmaceuticals Ltd (SMSPHARMA) on NSE touched a high of Rs 205 and a low of Rs 188
What price did SMS Pharmaceuticals Ltd (SMSPHARMA) shares open on the NSE today?
On NSE, the share price of SMS Pharmaceuticals Ltd (SMSPHARMA) opened at Rs 188
What is the 52-week high of SMS Pharmaceuticals Ltd (SMSPHARMA)?
The 52-week high price of SMS Pharmaceuticals Ltd (SMSPHARMA) is Rs 398
What is the 52-week low of SMS Pharmaceuticals Ltd (SMSPHARMA) ?
The 52-week low price of SMS Pharmaceuticals Ltd (SMSPHARMA) is Rs 175.25
Thank you! Your transaction has been completed successfully.
Sorry! Transaction failed. Please try again later.

DATA SOURCES: Corporate data, historical price & volume data published on this website have been sourced from CMOTS Internet Technologies Pvt. Ltd. BSE Quotes and NSE Quotes have been sourced from BSE Limited and NSE Data & Analytics Limited, respectively. All timestamps reflected here are in IST (Indian Standard Time). Stock Analysis section has been sourced from the mentioned partners.

DISCLAIMER: Any and all content on this website, including the tools/ analysis, is provided to you only for convenience and on an “as-is, as-available” basis without representation and warranties of any kind. The content and any output of such tools/ analysis is for informational purposes only and should not be relied upon or construed as investment advice or guarantee for any specific performance/ returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

By using this website, you agree to the Terms of Service and Privacy Policy.

Advertisement